2019 Biocom EIR - Los Angeles City Summary

Page 1

2019

CAL I F O R N I A ECONOMIC IMPACT REPORT CITY OF LOS ANGELES

$816 million

in research funding from National Institutes of Health (NIH) for FY2018. the total NIH funding 20% ofawarded to the State of

$78,817 Average annual earnings in City of Los Angeles for the Life Science industry.

513 Life Science establishments

California

The Impact of Life Science in City of Los Angeles The City of Los Angeles’ Life Science industry directly employed 21,231 people in 2018 with average annual earnings of $78,817. Total jobs in the city (direct/indirect/induced) was 58,778 in 2018 and economic activity generated $12B. There was solid job growth in Biopharmaceutical Manufacturing, Life Science Wholesale Trade and Research & Lab Services between 2013 and 2018. The Research & Lab Services subsector is performing well in City of Los Angeles compared to national averages and could be well-positioned for future growth.

Annual Economic Impact IMPACT Economic Activity

$12B

Market Value of Goods & Services

$7.1B

Total Jobs

58,778

(direct/indirect/induced)

Labor Income (salaries/wages/benefits paid)

$4.1B

NIH Funding California received more than $4.2B in NIH funding in fiscal year 2018 with $816M flowing to City of Los Angeles’ universities, labs and companies to support research in the life sciences industry. Two of the top five recipients in California were from City of Los Angeles: University of California, Los Angeles (UCLA) and University of Southern California (USC). Source: NIH (4/12/2019)

Subsector Employment & Establishments Employment in 2018

Establishments

BioRenewables Includes biofuels, specialty enzymes and chemicals, algae research, and key elements of agriculture

236

14

Biopharmaceutical Manufacturing The production of medicines, botanicals, pharmaceuticals, in-vitro diagnostic substances, and biological products.

1,388

31

427

15

2,219

174

Medical Devices & Diagnostic Equip Laboratory equipment and supplies, optical instruments, electromedical apparatus, surgical and medical instruments, and dental equipment. Life Science Wholesale Wholesaling and distributing medical equipment and supplies and the wholesaling of pharmaceuticals and related products. Research & Lab Services R&D in biotechnology, related areas of nanotechnology, medical laboratories, and portions of industries representing testing laboratories, other R&D services, and higher education.

16,961 279

‘Establishment’ refers to an individual facility/physical location. Some firms have multiple locations, which would each be counted separately.

For full report visit: www.biocom.org/eir


BIOCOM’S 2019 CALIFORNIA ECONOMIC IMPACT REPORT: CITY OF LOS ANGELES

Subsector Average Wage

City of Los Angeles

BioRenewables

BioPharmaceutical Manufacturing

Medical Devices & Diagnostic Equip

Life Science Wholesale

Research & Lab Services

All Life Sciences

$61,142

$103,164

$70,707

$89,984

$78,298

$78,817

Educational Attainment

11.6%

19.2% 17.8%

$4.1B

BioRenewables

22.8% High school diploma

Total

Graduate or Professional Degree

less than high school

22.4%

Foreign Exports of Life Science Products

Bachelor's Degree

6.1%

Biopharmaceutical Manufacturing Medical Devices & Diagnostic Equip

$.1B $.8B

Research & Lab Services

Some college

Industry

$1.3B

Life Science Wholesale Associate's Degree

Life Science

$.5B

$1.4B

0

0.3B

0.6B

0.9B

1.2B

1.5B

Lifes Science Innovation Companies City of Los Angeles has 140 Life Science Innovation Companies. Company Count

For full report visit: www.biocom.org/eir

BioRenewables

0

Biopharmaceutical Manufacturing

13

Medical Devices & Diagnostic Equip

12

Research & Development

115

’Life Science Innovation Company’ refers to companies in a subset of industry subsectors encompassing those who are doing work at the cutting edge of our industry (see full list of subsectors in Appendix 3 of Biocom’s 2019 California Economic Impact Report Databook). This should not be confused with ‘Establishments,’ which includes all physical locations of each company in the region in all industry subsectors.

Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 1,200 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.

This is a condensed summary of the Biocom’s 2019 California Economic Impact Report produced by Biocom and TClower & Associates. Note that as a result of the structural changes in our industry definitions/NAICS codes, the data and analysis in this edition of the Biocom California Life Science Economic Impact Report should not be compared to previous editions.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.